Catalyst Biosciences Receives Patents Covering its Hemostasis and Anti-Complement Programs
Go back to Catalyst Biosciences Receives Patents Covering its Hemostasis and Anti-Complement Programs| (NASDAQ: CBIO) | Delayed: 14.77 -1.67 (10.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.44 | 52 Week High | $4.57 | |||
| Open | $16.47 | 52 Week Low | $0.62 | |||
| Day High | $16.90 | P/E | N/A | |||
| Day Low | $14.51 | EPS | $0.00 | |||
| Volume | 526,074 | |||||

